Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a. White JT, Crossman M, Richter K, Berman M, Goyal J, Subramanyam M Bioanalysis. 2015 Nov 6. PMID: 26541956. Abstract CommentRecommendBookmarkWatch